Features

Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.

Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.

This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...

Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.

Familiarize yourself with up-and-coming allergens, including their chemical function, role in consumer products, and reported cases of contact allergy.